checkAd

    DGAP-News  539  0 Kommentare Cannabis Experts Join True Leaf Team for Final Marijuana Licensing Review Stage





    DGAP-News: True Leaf Medicine International Ltd. / Key word(s): Alliance/Regulatory Approval


    Cannabis Experts Join True Leaf Team for Final Marijuana Licensing Review Stage


    24.04.2017 / 09:10



    The issuer is solely responsible for the content of this announcement.



    Cannabis Experts Join True Leaf Team for Final Marijuana Licensing Review Stage



    Experts will advise on production facility design and build, security, and product testing before pre-license inspection



    Vancouver, Canada - (April 24, 2017) - True Leaf Medicine Inc. (True Leaf), a division of True Leaf Medicine International Ltd. (CSE: MJ, FSE: TLA), has engaged a number of cannabis experts to guide the company through the final stage in Health Canada's review of its application for a license to produce marijuana in Canada.



    Experts from industry-leading Pipe Dreemz Inc., Protect-IP Global Solutions Inc., Eurofins Scientific, and Ample Organics will be working with True Leaf over the next few weeks to prepare a review package for submission to Health Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR) application process.



    Health Canada recently upgraded the Marihuana for Medical Purposes Regulations (MMPR) application process to the ACMPR licensing program, so the experts will be working with True Leaf to update its original MMPR application to ensure True Leaf meets or exceeds the new compliance measures.



    "True Leaf is excited to have Pipe Dreemz, Protect-IP, Eurofins, and Ample Organics provide their expertise at this critical stage in the ACMPR review process," said True Leaf CEO Darcy Bomford. "We sought out experts from these companies because several of their clients have already been successful in the ACMPR process."



    True Leaf has engaged Pipe Dreemz CEO George Routhier, a premier consultant to companies going through Health Canada's Marihuana for Medical Purposes Regulations (MMPR) or ACMPR process since 2012. Mr. Routhier helps his clients navigate the complexities of the licensing process, specifically the design, construction, and operating procedures of marijuana production facilities. Pipe Dreemz is currently advising clients with over $150 million in production facilities under construction in Canada.

    Seite 1 von 3



    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    DGAP-News Cannabis Experts Join True Leaf Team for Final Marijuana Licensing Review Stage DGAP-News: True Leaf Medicine International Ltd. / Key word(s): Alliance/Regulatory Approval Cannabis Experts Join True Leaf Team for Final Marijuana Licensing Review Stage 24.04.2017 / 09:10 The issuer is solely responsible for the content of …